Crispr-related methods and compositions targeting cd70 expression
US-2026083861-A1 · Mar 26, 2026 · US
Editas Medicine Inc holds 180 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 180 |
| Recent patents | 59 |
| First publication | Aug 20, 2015 |
| Latest publication | Mar 26, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026083861-A1 · Mar 26, 2026 · US
US-12545912-B2 · Feb 10, 2026 · US
US-2026035693-A1 · Feb 5, 2026 · US
US-2026034247-A1 · Feb 5, 2026 · US
US-2026002159-A1 · Jan 1, 2026 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026083861-A1 · Mar 26, 2026 · US
US-12545912-B2 · Feb 10, 2026 · US
US-2026035693-A1 · Feb 5, 2026 · US
US-2026034247-A1 · Feb 5, 2026 · US
US-2026002159-A1 · Jan 1, 2026 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 176 |
| Human Necessities | 112 |
| Physics | 11 |
| Cross-Sectional Technologies | 3 |
Answers are generated from the same data shown on this page.